U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hearing abnormality

MedGen UID:
871365
Concept ID:
C4025860
Finding
Synonym: Abnormal hearing
 
HPO: HP:0000364

Definition

An abnormality of the sensory perception of sound. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHearing abnormality

Conditions with this feature

Bruck syndrome 1
MedGen UID:
342431
Concept ID:
C1850168
Disease or Syndrome
Bruck syndrome-1 (BRKS1) is characterized by congenital contractures with pterygia, onset of fractures in infancy or early childhood, postnatal short stature, severe limb deformity, and progressive scoliosis (McPherson and Clemens, 1997). Genetic Heterogeneity of Bruck Syndrome Bruck syndrome-2 (BRKS2; 609220) is caused by homozygous mutation in the PLOD2 gene (601865) on chromosome 3q24. Van der Slot et al. (2003) stated that they were unaware of any phenotypic differences between the 2 forms of Bruck syndrome.
Osteogenesis imperfecta type 7
MedGen UID:
343981
Concept ID:
C1853162
Disease or Syndrome
Osteogenesis imperfecta is a connective tissue disorder characterized by bone fragility and low bone mass. OI type VII is an autosomal recessive form of severe or lethal OI (summary by Barnes et al., 2006).
Tarsal-carpal coalition syndrome
MedGen UID:
348322
Concept ID:
C1861305
Disease or Syndrome
Tarsal-carpal coalition syndrome is a rare, inherited bone disorder that affects primarily the hands and feet. Several individual bones make up each wrist (carpal bones) and ankle (tarsal bones). In tarsal-carpal coalition syndrome, the carpal bones fuse together, as do the tarsal bones, which causes stiffness and immobility of the hands and feet. Symptoms of the condition can become apparent in infancy, and they worsen with age. The severity of the symptoms can vary, even among members of the same family.\n\nIn this condition, fusion at the joints between the bones that make up each finger and toe (symphalangism) can also occur. Consequently, the fingers and toes become stiff and difficult to bend. Stiffness of the pinky fingers and toes (fifth digits) is usually noticeable first. The joints at the base of the pinky fingers and toes fuse first, and slowly, the other joints along the length of these digits may also be affected. Progressively, the bones in the fourth, third, and second digits (the ring finger, middle finger, and forefinger, and the corresponding toes) become fused. The thumb and big toe are usually not involved. Affected individuals have increasing trouble forming a fist, and walking often becomes painful and difficult. Occasionally, there is also fusion of bones in the upper and lower arm at the elbow joint (humeroradial fusion). Less common features of tarsal-carpal coalition syndrome include short stature or the development of hearing loss.
Flat face-microstomia-ear anomaly syndrome
MedGen UID:
356655
Concept ID:
C1866962
Disease or Syndrome
A rare genetic multiple congenital anomalies/dysmorphic syndrome with characteristics of dysmorphic facial features including high forehead, elongated and flattened midface, arched and sparse eyebrows, short palpebral fissures, telecanthus, long nose with hypoplastic nostrils, long philtrum, high and narrow palate and microstomia with downturned corners. Ears are characteristically malformed, large, low-set and posteriorly rotated and nasal speech is associated.
Hypotrichosis 5
MedGen UID:
440568
Concept ID:
C2748535
Disease or Syndrome
Hypotrichosis-5 (HYPT5), also known as Marie Unna hereditary hypotrichosis-2 (MUHH2), is a form of hereditary hypotrichosis characterized by twisting hair. Affected individuals have little or no scalp hair at birth, wiry and irregular scalp hair in childhood, and sparse or no forehead and parietal hair at puberty. Eyebrows and eyelashes are thin, and pubic and axillary hair fails to develop. Scarring alopecia is modest, and vertex hair is normal (summary by Zhang et al., 2012). For a general phenotypic description of Marie Unna hereditary hypotrichosis, see MUHH1 (146550). For a discussion of genetic heterogeneity of nonsyndromic hypotrichosis, see 605389.
Question mark ears, isolated
MedGen UID:
411238
Concept ID:
C2748545
Anatomical Abnormality
Question mark ears (QME) is an auricular abnormality characterized by a cleft between the lobule and the lower part of the helix, sometimes accompanied by a prominent or deficient upper part of the helix, shallow skin dimple on the posterior surface of the ear, or transposition of the ear lobe/antitragus. It is more prevalent among boys than girls (2:1), usually sporadic, and can be unilateral or bilateral (Shkalim et al., 2008).
Hypotrichosis 9
MedGen UID:
481882
Concept ID:
C3280252
Disease or Syndrome
A hypotrichosis that has material basis in an autosomal recessive mutation on chromosome 10q11.23-q22.3.
Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
MedGen UID:
482853
Concept ID:
C3281223
Disease or Syndrome
Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is an autosomal recessive slowly progressive neurologic disorder characterized by imbalance due to cerebellar gait and limb ataxia with cerebellar atrophy on brain imaging, nystagmus, dysarthria, and peripheral sensory neuropathy with decreased or absent deep tendon reflexes. More variable features include vestibular dysfunction, chronic cough, autonomic dysfunction, saccadic pursuit, and pyramidal signs (extensor plantar responses). Most patients have onset in late adulthood, although earlier onset has been reported. Rare patients have features suggestive of lower motor neuron involvement (Szmulewicz et al., 2011, Miyatake et al., 2022).
Osteogenesis imperfecta type 17
MedGen UID:
903845
Concept ID:
C4225301
Disease or Syndrome
Osteogenesis imperfecta (OI) is a group of genetic disorders that mainly affect the bones. The term "osteogenesis imperfecta" means imperfect bone formation. People with this condition have bones that break (fracture) easily, often from mild trauma or with no apparent cause. Multiple fractures are common, and in severe cases, can occur even before birth. Milder cases may involve only a few fractures over a person's lifetime.\n\nThere are at least 19 recognized forms of osteogenesis imperfecta, designated type I through type XIX. Several types are distinguished by their signs and symptoms, although their characteristic features overlap. Increasingly, genetic causes are used to define rarer forms of osteogenesis imperfecta. Type I (also known as classic non-deforming osteogenesis imperfecta with blue sclerae) is the mildest form of osteogenesis imperfecta. Type II (also known as perinatally lethal osteogenesis imperfecta) is the most severe. Other types of this condition, including types III (progressively deforming osteogenesis imperfecta) and IV (common variable osteogenesis imperfecta with normal sclerae), have signs and symptoms that fall somewhere between these two extremes.\n\nOther types of osteogenesis imperfecta are more severe, causing frequent bone fractures that are present at birth and result from little or no trauma. Additional features of these types can include blue sclerae of the eyes, short stature, curvature of the spine (scoliosis), joint deformities (contractures), hearing loss, respiratory problems, and a disorder of tooth development called dentinogenesis imperfecta. Mobility can be reduced in affected individuals, and some may use a walker or wheelchair. The most severe forms of osteogenesis imperfecta, particularly type II, can include an abnormally small, fragile rib cage and underdeveloped lungs. Infants with these abnormalities may have life-threatening problems with breathing and can die shortly after birth.\n\nThe milder forms of osteogenesis imperfecta, including type I, are characterized by bone fractures during childhood and adolescence that often result from minor trauma, such as falling while learning to walk. Fractures occur less frequently in adulthood. People with mild forms of the condition typically have a blue or grey tint to the part of the eye that is usually white (the sclera), and about half develop hearing loss in adulthood. Unlike more severely affected individuals, people with type I are usually of normal or near normal height.
Long QT syndrome 1
MedGen UID:
1641146
Concept ID:
C4551647
Disease or Syndrome
Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.
Ectodermal dysplasia 14, hair/tooth type with or without hypohidrosis
MedGen UID:
1648329
Concept ID:
C4748560
Disease or Syndrome
Some ectodermal dysplasias are here classified as congenital disorders characterized by abnormal development in 2 or more ectodermal structures (hair, nails, teeth, and sweat glands) without other systemic findings. Ectodermal dysplasia-14 of the hair/tooth type (ECTD14) is primarily characterized by scalp hypotrichosis and hypodontia. Some patients have decreased sweating, and some show subtle facial dysmorphism (Peled et al., 2016). Rabie et al. (2022) tabulated the features of 24 patients with TSPEAR-associated ectodermal dysplasia, and found that of the various ectodermal derivatives, teeth were the most affected (82.6%), followed by hair (78.3%), nails (43.5%), and sweat glands (39.1%). The authors also noted that TSPEAR-associated dysmorphic facial features varied according to ethnic origin.
Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities
MedGen UID:
1781967
Concept ID:
C5543020
Disease or Syndrome
Neuronal ceroid lipofuscinosis-15 (CLN15) is characterized by severe global developmental delay apparent in infancy or early childhood. Affected individuals have hypotonia with impaired motor development, respiratory insufficiency, and feeding difficulties requiring intervention. Intellectual and speech development is also delayed, and most have visual defects, including cortical visual blindness, nystagmus, and esotropia. The disorder is progressive, as manifest by developmental regression consistent with neurodegeneration. Although overt seizures are not observed, some patients may have episodic hypertonia or apnea, and EEG may show nonspecific abnormalities. Brain imaging shows unique diffusion restriction signal abnormalities affecting the brainstem, cerebellum, and corticospinal tracts. Early death may occur (summary by Polovitskaya et al., 2020).

Professional guidelines

PubMed

Dalrymple SN, Lewis SH, Philman S
Am Fam Physician 2021 Jun 1;103(11):663-671. PMID: 34060792
Kashtan CE
Am J Kidney Dis 2021 Feb;77(2):272-279. Epub 2020 Jul 22 doi: 10.1053/j.ajkd.2020.03.026. PMID: 32712016
Michels TC, Duffy MT, Rogers DJ
Am Fam Physician 2019 Jul 15;100(2):98-108. PMID: 31305044

Recent clinical studies

Etiology

Richard C, Jeanvoine A, Stark AR, Hague K, Kjeldsen C, Maitre NL
J Pediatr 2022 Feb;241:103-108.e3. Epub 2021 Oct 25 doi: 10.1016/j.jpeds.2021.10.035. PMID: 34710395
Zhao S, He D, Zhang H, Hou T, Yang C, Ding W, He P
BMC Public Health 2021 Mar 6;21(1):460. doi: 10.1186/s12889-021-10496-3. PMID: 33676457Free PMC Article
Faria AOP, Miterhof MEVDCR, Vianna RAO, Carvalho FR, Dalcastel LAB, Oliveira SA, Fonseca SC, Riley LW, Velarde LGC, Cardoso CAA
Otol Neurotol 2020 Aug;41(7):e848-e853. doi: 10.1097/MAO.0000000000002704. PMID: 32569146
Phillips PS, Hirani SP, Epstein R
J Voice 2009 Sep;23(5):521-8. Epub 2008 May 12 doi: 10.1016/j.jvoice.2008.01.006. PMID: 18468850
Oysu C, Aslan I, Basaran B, Baserer N
Int J Pediatr Otorhinolaryngol 2001 Nov 1;61(2):129-34. doi: 10.1016/s0165-5876(01)00559-6. PMID: 11589979

Diagnosis

Zhao S, He D, Zhang H, Hou T, Yang C, Ding W, He P
BMC Public Health 2021 Mar 6;21(1):460. doi: 10.1186/s12889-021-10496-3. PMID: 33676457Free PMC Article
Faria AOP, Miterhof MEVDCR, Vianna RAO, Carvalho FR, Dalcastel LAB, Oliveira SA, Fonseca SC, Riley LW, Velarde LGC, Cardoso CAA
Otol Neurotol 2020 Aug;41(7):e848-e853. doi: 10.1097/MAO.0000000000002704. PMID: 32569146
Oysu C, Aslan I, Basaran B, Baserer N
Int J Pediatr Otorhinolaryngol 2001 Nov 1;61(2):129-34. doi: 10.1016/s0165-5876(01)00559-6. PMID: 11589979
Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P
Am J Clin Oncol 1999 Jun;22(3):305-8. doi: 10.1097/00000421-199906000-00020. PMID: 10362343
Richards A, Brain C, Dillon MJ, Bailey CM
J Laryngol Otol 1996 Apr;110(4):328-38. doi: 10.1017/s0022215100133560. PMID: 8733453

Therapy

Richard C, Jeanvoine A, Stark AR, Hague K, Kjeldsen C, Maitre NL
J Pediatr 2022 Feb;241:103-108.e3. Epub 2021 Oct 25 doi: 10.1016/j.jpeds.2021.10.035. PMID: 34710395
Zhao S, He D, Zhang H, Hou T, Yang C, Ding W, He P
BMC Public Health 2021 Mar 6;21(1):460. doi: 10.1186/s12889-021-10496-3. PMID: 33676457Free PMC Article
Mitsuiki N, Tamanuki K, Sei K, Ito J, Kishi A, Kobayashi K, Hatai Y, Nagasawa M
J Infect Chemother 2017 Feb;23(2):107-110. Epub 2016 Sep 11 doi: 10.1016/j.jiac.2016.08.007. PMID: 27627852
Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P
Am J Clin Oncol 1999 Jun;22(3):305-8. doi: 10.1097/00000421-199906000-00020. PMID: 10362343
Richards A, Brain C, Dillon MJ, Bailey CM
J Laryngol Otol 1996 Apr;110(4):328-38. doi: 10.1017/s0022215100133560. PMID: 8733453

Prognosis

Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P
Am J Clin Oncol 1999 Jun;22(3):305-8. doi: 10.1097/00000421-199906000-00020. PMID: 10362343
Richards A, Brain C, Dillon MJ, Bailey CM
J Laryngol Otol 1996 Apr;110(4):328-38. doi: 10.1017/s0022215100133560. PMID: 8733453

Clinical prediction guides

Faria AOP, Miterhof MEVDCR, Vianna RAO, Carvalho FR, Dalcastel LAB, Oliveira SA, Fonseca SC, Riley LW, Velarde LGC, Cardoso CAA
Otol Neurotol 2020 Aug;41(7):e848-e853. doi: 10.1097/MAO.0000000000002704. PMID: 32569146
Khan NA, Govindaraj P, Jyothi V, Meena AK, Thangaraj K
Mol Vis 2013;19:1282-9. Epub 2013 Jun 11 PMID: 23805034Free PMC Article
Nagy JL, Adelstein DJ, Newman CW, Rybicki LA, Rice TW, Lavertu P
Am J Clin Oncol 1999 Jun;22(3):305-8. doi: 10.1097/00000421-199906000-00020. PMID: 10362343

Recent systematic reviews

Debenham L, Khan N, Nouhan B, Muzaffar J
Eur Arch Otorhinolaryngol 2024 May;281(5):2223-2233. Epub 2024 Jan 8 doi: 10.1007/s00405-023-08393-z. PMID: 38189970

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...